CNKI中矮小症高被引文献的计量分析
Quantitative Analysis of Highly Cited Literature on Dwarfism in CNKI
DOI: 10.12677/ACM.2023.1392120, PDF, HTML, XML, 下载: 298  浏览: 383 
作者: 李海霞, 谢坤霞*:延安大学附属医院儿科,陕西 延安
关键词: 矮小症生长激素缺乏儿童Dwarfism Growth Hormone Deficiency Children
摘要: 目的:总结2010年1月1日至2020年12月18日2012年新版中国学术期刊全文数据库(CNKI)中儿童矮小症高被引文文献的计量分析,为临床科研提供依据。方法:查阅2012年新版中国学术期刊全文数据库(CNKI)手机2010年1月1日至2021年12月18日发表在国内医学期刊上有关儿童矮小症的文献。制定纳入标准,排除标准,进行文献筛选,计量分析,从而得到矮小症高被引文数量。结果:符合纳入标准不符合排除标准文献总计CNKI含2010~2020年的矮小症文献457篇。其中,高被引文献101篇,占总文献22.10%。矮小症高被引文献2010~2013年呈曲线增长,年均8篇;2014~2015年呈直线上升,年均10篇,2015年达至峰值20篇后迅速下降至2016年的11篇,之后2016~2017年呈直线上升,年均13.5篇,自2017年后至2020年逐年下降,年平均7.5篇。101篇矮小症高被引文献来自76种期刊,总载文比1.33。101篇矮小症高被引文献涉及作者312人、署名372人次。101篇矮小症的高被引文献共涉及机构156个。101篇矮小症高被引文献均列有关键词2~9个,共涉及关键词189个、417次,篇均关键词1.87个。结论:近年来,矮小症诊治引起了更多专家关注,矮小症相关文献研究逐年增多,应更加正确指导家长对儿童矮小症的关注。
Abstract: Objective: To summarize the metrological analysis of highly cited literature on childhood dwarfism in the new version of China Academic Journal Full Text Database (CNKI) in 2012 from January 1, 2010 to December 18, 2020, to provide a basis for clinical research. Methods: Literature on child-hood dwarfism published in domestic medical journals from January 1, 2010 to December 18, 2021 in the 2012 new edition of China Academic Journals Full Text Database (CNKI) was reviewed. Inclu-sion criteria, exclusion criteria, literature screening, and econometric analysis were developed to obtain the number of highly cited articles on dwarfism. Results: The total CNKI included 457 litera-tures on nanosomia from 2010 to 2020 that met the inclusion criteria but did not meet the exclu-sion criteria. Among them, 101 articles were highly cited, accounting for 22.10% of the total litera-ture. The highly cited literature on dwarfism showed a curvilinear growth from 2010 to 2013, with an average of 8 articles per year; it showed a linear increase from 2014 to 2015, with an average of 10 articles per year; it reached a peak of 20 articles in 2015 and then rapidly declined to 11 articles in 2016, after which it showed a linear increase from 2016 to 2017 with an average of 13.5 articles per year, and then it declined year by year from 2017 to 2020 with an annual average of 7.5 arti-cles. 101 highly cited literatures on dwarfism were found in CNKI, accounting for 22.10% of the total literature. The 101 highly cited literature on dwarfism came from 76 journals, with a total load ratio of 1.33. The 101 highly cited literature on dwarfism involved 312 authors and 372 signatures. The 101 highly cited literature on dwarfism involved a total of 156 institutions. The 101 highly cited literatures on dwarfism all listed keywords ranging from 2 to 9, with a total of 189 keywords, 417 times, and an average keyword per article of 1.87 keywords. Conclusion: In recent years, the diag-nosis and treatment of dwarfism has attracted more attention from experts, and the literature re-search related to dwarfism has increased year by year, which should more correctly guide parents to pay attention to children’s dwarfism.
文章引用:李海霞, 谢坤霞. CNKI中矮小症高被引文献的计量分析[J]. 临床医学进展, 2023, 13(9): 15160-15167. https://doi.org/10.12677/ACM.2023.1392120

1. 引言

矮小症是指与同年龄、同性别儿童相比较,身高低于正常儿童身高的2 s (标准差)以上,或者低于正常儿童生长曲线的第3个百分位 [1] 。矮小症是儿童生长发育的常见问题,生长激素缺乏症是其多见的类型,相关研究众多 [2] [3] [4] 。但国内文献局限在矮小症病因病机、诊断治疗、心理影响等方面,尚无学者对文献本身的特征进行研究。运用文献计量学方法,分析文献特征,有助于掌握相关研究现状,研判未来发展趋势,日益受到学者重视。为此,本文对国内矮小症高被引文献进行了计量分析。

2. 文献与方法

2.1. 文献获取

选2012年新版中国学术期刊全文数据库(CNKI),于2020年12月18日,用精确匹配,主题词 = “矮小症”、发表时间为2010年1月1日至2020年12月18日的文献。

2.2. 高被引文献确定

借用普赖斯定律确定核心机构的方法,被引频次 N = 0.746 η max 以上的文献为高被引文献。其中ηmax,为最高被引频次。结果ηmax = 42,N = 4.85,即被引频次≥ 5的文献为高被引文献。

2.3. 指标及统计

改手工。交叉重复和一稿多投的文献,只保留被引频次最高者,并入相应剔除文献的被引频次。将期刊名称、发表年份、作者姓名、作者单位、关键词、基金名称、被引频次输入Excel2010,2人校对无误后统计分析。

3. 结果

3.1. 一般结果

CNKI含2010~2020年的矮小症文献457篇。其中,被引文献241篇,占52.73%;高被引文献101篇,占总文献22.10%、累计被引1208次,篇均被引11.96次,其中,54篇被引5~9次,占53.47%;18篇被引10~14次,占17.82%;13篇被引15~19次,占12.87%;15篇被引20~38次,占14.85%;1篇被引42次,占0.99%。

3.2. 发表年份

矮小症高被引文献2010年~2013年呈曲线增长,年均8篇;2014~2015年呈直线上升,年均10篇,2015年达至峰值20篇后迅速下降至2016年的11篇,之后2016~2017年呈直线上升,年均13.5篇,自2017年后至2020年逐年下降,年平均7.5篇。见图1

Figure 1. Annual distribution of highly cited literature on CNKI dwarfism

图1. CNKI矮小症高被引文献年度分布

3.3. 载文期刊

101篇矮小症高被引文献来自76种期刊,总载文比1.33。表1显示,《中国中西医结合儿科学》、《中国儿童保健杂志》、《临床儿科杂志》、《中国现代医生》、《中国诊断学电子杂志》的文献数依次居前5位,《临床儿科杂志》、《中国中西医结合儿科学》、《中国儿童保健杂志》、《第三军医大学学报》、《中国当代儿科杂志》的总被引频次依次居前5位。其中,《中国中西医结合儿科学》、《中国儿童保健杂志》、《临床儿科杂志》、《中国现代医生》、《中国诊断学电子杂志》共载文26篇、累计被引361次,占高被引文献25.74%、高被引文献总被引频次29.88%。见表1

Table 1. Distribution of journals with high citation frequency, total citation frequency, and average citation frequency for CNKI dwarfism

表1. CNKI矮小症高被引文献数量、总被引频次、篇均被引频次的期刊分布

3.4. 文献作者

101篇矮小症高被引文献涉及作者312人、署名372人次。其中,署名9次1人,署名7次1人,署名6次1人,署名5次3人,署名4次1人,署名3次1人,署名2次24人,独撰16篇,占15.84%;2人合作28篇,占27.72%;3人合作14篇,占13.86%;4人合作7篇,占6.93%;5人合作12篇,占11.88%;6人合作10篇,占9.90%;7人合作8篇,占7.92%;8人合作3篇,占2.97%;9人合作1篇,占0.99%;10人合作1篇,占0.99%;11人合作1篇,占0.99%。见表2

Table 2. Author distribution of CNKI dwarfism high cited literature

表2. CNKI矮小症高被引文献作者分布

3.5. 作者机构

将n人合作的文献每人计1/n篇 [5] - [45] 、大学附属医院的文献计入相应大学、并校前的文献计入并校后相应大学、机构更名前的文献计入更名后机构,101篇矮小症的高被引文献共涉及机构156个。其中,医院82个(52.56%)、院校72个(46.15%)、研究所2个(1.28%)。最高产发文机构为济宁医学院,13篇。根据普赖斯定律,核心发文机构文献数≥2.07篇,共5个,折合发文19.25篇,涉及文献30篇,占高被引文献29.70%。其中,院校16个、医院9个、科研院所1个,依次占61.54%、34.62%、3.84%。署有济宁医学院、山东大学医学院、北京协和医院、复旦大学、南京医科大学、湖南省人民医院、西安交通大学、安徽医科大学、台州恩泽医疗中心的文献数居前9位,依次为13篇、5篇、4篇、4篇、4篇、4篇、3篇、3篇、3篇,见表3

Table 3. Core publishing institutions of highly cited literature on CNKI dwarfism

表3. CNKI矮小症高被引文献的核心发文机构

3.6. 关键词

101篇矮小症高被引文献均列有关键词2~9个,共涉及关键词189个、417次,篇均关键词1.87个。其中,使用2个、3个、4个、5个、6个、7个、8个、9个关键词的文献,分别有3篇、30篇、35篇、25篇、4篇、2篇、1篇、1篇,依次占2.97%、29.70%、34.65%、24.75%、3.96%、1.98%、1.00%、1.00%。关键词“矮小症”、“儿童”、“生长激素”、“重组生长激素”、“病因”、“精氨酸”、“身高”、“激发试验”、“生长激素激发试验”、“左旋多巴”的使用频次居前10位。见表4

Table 4. Distribution of keywords in highly cited literature on CNKI dwarfism

表4. CNKI矮小症高被引文献关键词分布

3.7. 基金类别

在101篇矮小症高被引文献中,获基金支持的文献共32篇,占31.68%;累计39项次,篇均1.22项次。其中,“十二五”国家科技支撑计划项目1项次、自然科学基金6个项次、省级基金15项次、市级基金12项次。

NOTES

*通讯作者。

参考文献

[1] Bitarafan, F., Khodaeian, M., Garrousi, F., Khalesi, R., Ghazi, N.D., Karimi, B., Alibakhshi, R. and Garshasbi, M. (2023) Reporting a Novel Growth Hormone Receptor Gene Variant in an Iranian Consanguineous Pedigree with Laron Syndrome: A Case Report. BMC Endocrine Disorders, 23, Article No. 155.
https://doi.org/10.1186/s12902-023-01388-1
[2] 郭静, 王彬彬, 康慧慧. 重组人生长激素联合认知行为疗法对特发性矮小症患儿生长发育状况及胰岛素生长因子水平的影响[J]. 临床医学工程, 2023, 30(7): 933-934.
[3] 郭莹, 刘洋. 不同剂量重组人生长激素对非生长激素缺乏性矮小症患儿生长激素-胰岛素样生长因子轴的影响[J]. 临床药物治疗杂志, 2023, 21(6): 49-52.
[4] 詹红艳. 中医培元助长多元疗法治疗青春期前特发性矮小症临床观察[J]. 光明中医, 2023, 38(13): 2553-2555.
[5] 孙志惠. 孩子身材矮小不能忽视[J]. 开卷有益-求医问药, 2023(6): 9-10.
[6] Lange Elizabeth, M.S., Toledo, P., Stariha, J., Li Mandri, J., Morley, D. and Nixon, H.C. (2023) Bupivacaine Dosing for Cesarean Delivery in Parturients of Short Stature: A Retrospective Case-Control Study. AANA Journal, 91, 206-210.
[7] Sharvill, J. (2023) Short Stature—What Specific Test Should We Request? The British Journal of General Practice: The Journal of the Royal College of General Practitioners, 73, 254-255.
https://doi.org/10.3399/bjgp23X732945
[8] Hadid, Y., Daher, Z., Mahroum, M., Shalata, A., Nakhleh, F.Y., Shalata, H., et al. (2023) Identification of a Novel LTBP3 Gene Pathogenic Variant in Druze Arab Patients Presented with Syndromic Short Stature with Brachyolmia and Amelogenesis Imperfecta. Harefuah, 162, 352-358.
[9] Hahm, S., Lee, B., Bok, G., Kim, S. and Park, J. (2023) Diniconazole Promotes the Yield of Female Hemp (Cannabis sativa) In-florescence and Cannabinoids in a Vertical Farming System. Agronomy, 13, Article No. 1497.
https://doi.org/10.3390/agronomy13061497
[10] Ferdousi, T., Banu, H., Sultana, N., Mahrukh, H. and Hasanat, M.A. (2023) Turner Syndrome with Isochromosome Structural Abnormalities: A Case Report. Cureus, 15, e40516.
https://doi.org/10.7759/cureus.40516
[11] Liu, X., Zhao, C.X., Wang, D., Pan, G., Ji, X.N., Gao, S., Du, T.X., Feng, Y.T. and Chen, W.J. (2023) DDG1 and G Protein α Subunit RGA1 Interaction Regulates Plant Height and Senes-cence in Rice (Oryza sativa). Phyton-International Journal of Experimental Botany, 92, 2051-2064.
https://doi.org/10.32604/phyton.2023.028196
[12] 相媛媛, 杜维维, 高世全, 李学超, 王建忠. 特发性矮小症患儿rhGH治疗前后血清BMP-2、TAZ水平变化及其预后价值[J]. 标记免疫分析与临床, 2023, 30(5): 805-810.
[13] 叶薇, 原丹, 李君君, 李婵. 肖诏玮生长1号方治疗肾精亏损型特发性矮小症小鼠的效果[J]. 临床合理用药, 2023, 16(15): 128-130.
[14] Roddate, M., Tauriņa, G., Krutovs, V., Rots, D. and Kēniņa, V. (2023) Mother and Daughter with Short Stature, Microcephaly, Mild Dysmorphic Features, and Learning Disabilities due to Ver-veri-Brady Syndrome Associated with a New Variant of the QRICH1 Gene. The American Journal of Case Reports, 24, e939217.
https://doi.org/10.12659/AJCR.939217
[15] Hwang, S.W., Hwang, K. and Tukeshov, S.K. (2023) Craniofacial Features of Dwarfism in the Paintings of Velázquez. The Journal of Craniofacial Surgery, 34, 1804-1806.
https://doi.org/10.1097/SCS.0000000000009368
[16] 何炜, 王琴, 王俐. 矮小症患儿维生素D水平及影响因素分析[J]. 中国健康教育, 2023, 39(5): 474-479.
[17] 陈林睿, 杨青. 中药治疗儿童矮小症疗效Meta分析[J]. 中医临床研究, 2023, 15(14): 108-114.
[18] Sun, F.P., Chao, L.Q., Zhang, J.X. and Pan, X.L. (2023) Exercise Combined with Lysine-Inositol Vitamin B12 Promotes Height Growth in Children with Idiopathic Short Stature. Growth Hormone & IGF Research: Official Journal of the Growth Hormone Research Society and the International IGF Research Society, 69-70, Article ID: 101535.
https://doi.org/10.1016/j.ghir.2023.101535
[19] 王丹丹, 季兴. 基因重组生长激素的合理应用及规范化治疗[J]. 中国合理用药探索, 2023, 20(5): 20-22.
[20] 曹玉霞. 特发性矮小症患儿血清miR-21水平表达及意义探讨[J]. 中国妇幼保健, 2023, 38(10): 1816-1819.
[21] 江明明. 不同生长激素水平下矮小症儿童血压、体质指数与丙氨酸氨基转移酶的相关性研究[D]: [硕士学位论文]. 济宁: 济宁医学院, 2023.
[22] 杨如雪. 母亲月经初潮年龄与矮小症儿童人体测量和代谢指标的相关性研究[D]: [硕士学位论文]. 济宁: 济宁医学院, 2023.
[23] 李广欣. 矮小症患者代谢指标与丙氨酸氨基转移酶的相关性研究[D]: [硕士学位论文]. 济宁: 济宁医学院, 2023.
[24] Bogarin, R., Elizondo, L., Kalaitzoglou, E., Popovic, J., Rogol, A., Richmond, E., et al. (2023) Bringing the Pediatric Endocrine Spanish Speaking Community Together: First Virtual Pediatric Endocrine Meeting in Low- and Mid-dle-Income Countries in Central and South America. Interactive Journal of Medical Research, 12, e41353.
https://doi.org/10.2196/41353
[25] Tang, H.W., Fan, J.L., Wang, R., Zhu, J.H., Xiang, X.Z., Dong, J.F., Zhou, L.Y. and Wang, L.M. (2023) Changes in the Expression Pattern of OsWUS Negatively Regulate Plant Stature and Pani-cle Development in Rice. G3 (Bethesda, Md.), 13, jkad100.
https://doi.org/10.1093/g3journal/jkad100
[26] Shi, Y.Z., Ying, Y.Q., Luo, X.P. and Hou, L. (2023) Growth Hormone Treatment in Children with Perthes Disease and Growth Hormone Deficiency: A Case Report and Literature Review. Endocrine, Metabolic & Immune Disorders Drug Targets.
[27] Abernethy, L. and Tinklin, T. (2023) Managing Expectations in the Child of Short Stature with No Un-derlying Cause. Paediatrics and Child Health, 33, 144-147.
https://doi.org/10.1016/j.paed.2023.02.004
[28] Malik, S.E., Kanwal, S., Javed, J., Hidayat, W., Ghaffar, T. and Aamir, A.H. (2023) Endocrine Disorders in Beta-Thalassemia Major Patients at a Tertiary Care Hospital. Pakistan Journal of Medical Sciences, 39, 726-731.
https://doi.org/10.12669/pjms.39.3.6837
[29] Jammaers, E. and Ybema, S. (2023) Oddity as Commodity? The Body as Symbolic Resource for Other-Defying Identity Work. Organization Studies, 44, 785-805.
https://doi.org/10.1177/01708406221077770
[30] Roy, R., Hazra, A. and Ghosh, S. (2023) An Observational Study on Response to Growth Hormone Therapy in Indian Patients of Short Stature with Special Emphasis on Biochem-ical Parameters and Bone Biomarkers. Indian Journal of Endocrinology and Metabolism, 27, 260-269.
https://doi.org/10.4103/ijem.ijem_303_22
[31] Khadilkar, A.V., Oza, C., Mondkar, S.A., Khadilkar, V., Kanungo, A., Sethi, B.K., et al. (2023) Nutritional Status of Underprivileged Indian Children and Youth with Type-1 Diabetes—A Multicentre Study. Indian Journal of Endocrinology and Metabolism, 27, 216-222.
https://doi.org/10.4103/ijem.ijem_224_22
[32] 苏洁惠. 基于骨龄X线片影像组学模型在儿童生长激素缺乏症诊断中的价值[D]: [硕士学位论文]. 杭州: 浙江中医药大学, 2023.
[33] 陈笑雅. 大补阴丸联合生长贴对青春早期偏矮女童预测成年身高的影响[D]: [硕士学位论文]. 杭州: 浙江中医药大学, 2023.
[34] Ke, X.A., Yang, H.B., Pan, H., Jiang, Y.L., Li, M.M., Zhang, H.Z., Hao, N. and Zhu, H.J. (2023) The Application of Optical Genome Mapping (OGM) in Severe Short Stature Caused by Duplication of 15q14q21.3. Genes, 14, 1016.
https://doi.org/10.3390/genes14051016
[35] 罗亚飞. 碳酸钙联合重组人生长激素治疗特发性矮小症的临床研究[J]. 现代诊断与治疗, 2023, 34(8): 1176-1178.
[36] Erin, P. (2023) Midgetism: The Exploitation and Discrimination of People with Dwarfism. Taylor and Francis, Abingdon-on-Thames.
https://doi.org/10.4324/9781003382461
[37] 李琼, 张菲菲, 张旭, 杜宁. 生长激素缺乏型矮小症患儿食物不耐受检测及其意义[J]. 中国实验诊断学, 2023, 27(4): 444-447.
[38] 王维, 陈洋, 唐雨莉, 向红. 矮小症儿童临床特征及相关危险因素分析[J]. 中国中西医结合儿科学, 2023, 15(2): 133-137.
[39] Pérez-Pérez, A., Alonso, A.A., González, G.A. and Riaño, G.I. (2023) Tratamiento con hormona de crecimiento en pediatría, qué podemos mejorar? Endocrinología, Diabetes y Nutrición, 70, 313-318.
https://doi.org/10.1016/j.endinu.2023.02.012
[40] Kamoun, C., Miller, V.A., Feudtner, C., Friedrich, E.A. and Grimberg, A. (2023) Views on Short Stature of Female versus Male Endocrine Pediatric Patients Undergoing Provoca-tive Growth Hormone Testing and Their Parents. Endocrine Practice: Official Journal of the American College of Endo-crinology and the American Association of Clinical Endocrinologists, 29, 517-524.
https://doi.org/10.1016/j.eprac.2023.04.004
[41] 谢小菲, 黄转弟. γ-氨基丁酸干预对矮小症儿童生长发育的影响[J]. 吉林医学, 2023, 44(4): 1015-1018.
[42] 邓福平, 陈丹丹, 李燕燕. 不同剂量重组人生长激素对特发性矮小症患儿血清IGF-1和IGFBP-3表达的影响[J]. 中国医学创新, 2023, 20(11): 35-39.
[43] Nielsen, D.E., Ruegg, M.S.G. and Bicknell, L.S. (2023) The Expanding Genetic and Clinical Landscape Associated with Meier-Gorlin Syn-drome. European Journal of Human Genetics: EJHG, 31, 859-868.
https://doi.org/10.1038/s41431-023-01359-z
[44] 窦豆, 朱晓华, 刘钊. 特发性矮小儿童影响因素的Logistic回归方程分析及骨密度与体格发育关系[J]. 医学理论与实践, 2023, 36(7): 1206-1208.
[45] 张欣冉, 张梅, 李艳英, 晏文华, 张艳红, 邵倩, 贺栋业, 陈树雄, 班博. 矮小症生物样本库建立与管理[J]. 中国医药生物技术, 2023, 18(2): 162-164.